Backs FY24 revenue view $3.865B-$3.890B, consensus $3.88B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- Idexx Laboratories CFO Brian McKeon to retire, Andrew Emerson to succeed
- Idexx Laboratories Announces CEO Jonathan Ayers’ Resignation
- Idexx Laboratories price target lowered to $435 from $520 at Piper Sandler
- Idexx Laboratories price target lowered to $481 from $570 at Barclays
- IDEXX Laboratories Reports Robust Q3 2024 Performance